Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Non-Current Debt (2017 - 2023)

Marimed (MRMD) has disclosed Non-Current Debt for 7 consecutive years, with $18.9 million as the latest value for Q3 2023.

  • On a quarterly basis, Non-Current Debt changed N/A to $18.9 million in Q3 2023 year-over-year; TTM through Sep 2023 was $18.9 million, a N/A change, with the full-year FY2021 number at $17.3 million, up 61.6% from a year prior.
  • Non-Current Debt was $18.9 million for Q3 2023 at Marimed, down from $20.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $20.8 million in Q1 2023 to a low of $46000.0 in Q1 2022.
  • A 5-year average of $9.5 million and a median of $10.7 million in 2020 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: plummeted 98.58% in 2022, then soared 45123.91% in 2023.
  • Marimed's Non-Current Debt stood at $300000.0 in 2019, then soared by 3460.74% to $10.7 million in 2020, then surged by 61.6% to $17.3 million in 2021, then plummeted by 99.73% to $46000.0 in 2022, then soared by 40976.09% to $18.9 million in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Non-Current Debt are $18.9 million (Q3 2023), $20.5 million (Q2 2023), and $20.8 million (Q1 2023).